Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

ClinicalTrials.gov ID: NCT02270099

Public ClinicalTrials.gov record NCT02270099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical performance study is being conducted to evaluate the performance of the Aptima Herpes Simplex Viruses 1 \& 2 assay for detection of herpes simplex virus (HSV) type 1 (HSV-1) and HSV type 2 (HSV-2) in swab samples prospectively collected from suspected HSV lesions. Specimens collected using swabs from viral transport medium (VTM)collection kits and Aptima swab collection kits will be evaluated.

Study identification

NCT ID
NCT02270099
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Hologic, Inc.
Industry
Enrollment
839 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2014 (Type not available)
Primary completion
Aug 2016 (Actual)
Completion
Jun 2017 (Actual)
Last update posted
Aug 14, 2017

2014 – 2017

United States locations

U.S. sites
22
U.S. states
19
U.S. cities
22
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Elite Clinical Studies, LLC Phoenix Arizona 85018 —
Sherif Khamis MD, Inc Canoga Park California 91303 —
Mills Clinical Research Los Angeles California 90069 —
Planned Parenthood of the Rocky Mountains Denver Colorado 80206 —
Yale School of Medicine New Haven Connecticut 06510 —
Perimeter Institute for Clinical Research, Inc. (PICR Clinic) Atlanta Georgia 30338 —
Advanced Clinical Research Boise Idaho 83642 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
LSU Health Science Center New Orleans Louisiana 70112 —
LSU Health Science Center - Shreveport Shreveport Louisiana 71103 —
IRC Clinics Towson Maryland 21204 —
University of Mississippi Medical Center/Crossroads Clinic (MSDH) Jackson Mississippi 39216 —
Quality Clinical Research Inc. Omaha Nebraska 68114 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Laboratory Corporation of America Burlington North Carolina 27215 —
Westover Heights Clinic Portland Oregon 97210 —
Planned Parenthood of Southeastern Pennsylvania Philadelphia Pennsylvania 19107 —
Geneuity Clinical Research Services Maryville Tennessee 37804 —
Planned Parenthood Gulf Coast, Inc. Houston Texas 77023 —
Center for Clinical Studies Webster Texas 77598 —
American Regional University Pathologists Salt Lake City Utah 84108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02270099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02270099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →